Stryker (SYK) Shareholder's Equity Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66.31% |
| Dec 31, 2025 | 12.46% |
| Sep 30, 2025 | 10.90% |
| Jun 30, 2025 | 248.10% |
| Mar 31, 2025 | 104.31% |
| Dec 31, 2024 | -17.10% |
| Sep 30, 2024 | 10.35% |
| Jun 30, 2024 | -15.07% |
| Mar 31, 2024 | -51.56% |
| Dec 31, 2023 | 11.55% |
| Sep 30, 2023 | 12.67% |
| Jun 30, 2023 | 42.22% |
| Mar 31, 2023 | 58.94% |
| Dec 31, 2022 | 22.10% |
| Sep 30, 2022 | 9.57% |
| Jun 30, 2022 | -67.22% |
| Mar 31, 2022 | -27.48% |
| Dec 31, 2021 | 6.94% |
| Sep 30, 2021 | 8.72% |
| Jun 30, 2021 | -16.04% |
| Mar 31, 2021 | -27.16% |
| Dec 31, 2020 | 220.24% |
| Sep 30, 2020 | 8.89% |
| Jun 30, 2020 | -66.11% |
| Mar 31, 2020 | -15.72% |
| Dec 31, 2019 | 112.02% |
| Sep 30, 2019 | 7.39% |
| Jun 30, 2019 | -29.49% |
| Mar 31, 2019 | -29.86% |
| Dec 31, 2018 | 3.54% |
| Sep 30, 2018 | 2.45% |
| Jun 30, 2018 | -15.60% |
| Mar 31, 2018 | -29.37% |
| Dec 31, 2017 | -72.31% |
| Sep 30, 2017 | 4.51% |
| Jun 30, 2017 | 4.76% |
| Mar 31, 2017 | 3.88% |
| Dec 31, 2016 | -15.99% |
| Sep 30, 2016 | 4.31% |
| Jun 30, 2016 | 3.18% |
| Mar 31, 2016 | 3.40% |
| Dec 31, 2015 | -65.13% |
| Sep 30, 2015 | 3.03% |
| Jun 30, 2015 | 4.74% |
| Mar 31, 2015 | 4.52% |
| Dec 31, 2014 | -64.35% |
| Sep 30, 2014 | 6.01% |
| Jun 30, 2014 | 8.25% |